AMPH vs PCRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: May 08, 2026

AMPH

44.2
AI Score
VS
PCRX Wins

PCRX

55.3
AI Score

Investment Advisor Scores

AMPH

44score
Recommendation
HOLD

PCRX

55score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric AMPH PCRX Winner
Forward P/E 0 10.1626 Tie
PEG Ratio 2.77 11.2121 AMPH
Revenue Growth -1.8% 5.0% PCRX
Earnings Growth -31.0% -30.0% PCRX
Tradestie Score 44.2/100 55.3/100 PCRX
Profit Margin 13.6% 0.7% AMPH
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, PCRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.